{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:35:38Z","timestamp":1792920938085,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Natural Science Research Project of Anhui Province"},{"name":"University Natural Science Research Project of Anhui Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Colorectal cancer is a common digestive malignancy. Neoadjuvant chemotherapy (NAC) can downstage tumors and increase R0 resection rates. In colorectal cancer specimens with favorable pathological regression after NAC, we observed CD68\n                    <jats:sup>+<\/jats:sup>\n                    multinucleated giant cells (MGCs) preferentially localized in apoptotic cell-rich areas, whereas they were rarely detected in non-NAC specimens. However, the mechanisms driving MGC formation and their functional significance remain unclear. We established an in vitro apoptotic cell-macrophage co-culture system to assess how apoptotic cell burden and efferocytosis regulate macrophage fusion. The TREM2\/TYROBP signaling axis was examined using molecular and pharmacological approaches. RNA sequencing, pathway enrichment, lysosome- and metabolism-related transcriptional analyses, and secretory profiling were performed to characterize efferocytosis-induced MGCs. Their effects on colorectal cancer cells and the tumor microenvironment were further evaluated in vitro and in tumor-bearing mouse models. Excessive apoptotic cell burden markedly promoted macrophage fusion and upregulated the fusion-related molecules DCSTAMP\/Dcstamp and CDH1\/Cdh1. Apoptotic cell overload shifted macrophages from a homeostatic\/efferocytic state toward a fusion-prone MGC phenotype.\n                    <jats:italic>TYROBP<\/jats:italic>\n                    \/\n                    <jats:italic>Tyrobp<\/jats:italic>\n                    knockdown or loss inhibited macrophage fusion. Mechanistically, apoptotic cell overload activated the TREM2\/TYROBP-MAPK\/c-FOS-DCSTAMP axis, thereby enhancing\n                    <jats:italic>DCSTAMP<\/jats:italic>\n                    transcription and macrophage fusion. Efferocytosis-induced MGCs showed reduced lysosome-related transcriptional programs and an altered secretory profile, including increased TNF-\u03b1 expression. Functionally, MGCs inhibited colorectal cancer cell growth in vitro. In tumor-bearing mice, MGCs reduced CD206\u207a macrophage and regulatory T-cell abundance while increasing CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell infiltration, thereby contributing to tumor growth suppression. Together, these findings identify efferocytosis-induced MGCs as a distinct macrophage state with altered lysosomal and secretory programs, anti-tumor activity, and the potential to remodel the tumor microenvironment.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09320-w","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:38:41Z","timestamp":1791211121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apoptotic cell overload drives multinucleated giant cell formation after neoadjuvant chemotherapy in colorectal cancer: molecular mechanisms and tumor-suppressive effects"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiaxin","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-8423","authenticated-orcid":false,"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"9320_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrae038","volume":"8","author":"HG Smith","year":"2024","unstructured":"Smith HG, Nilsson PJ, Shogan BD, Harji D, Gambacorta MA, Romano A, et al. Neoadjuvant treatment of colorectal cancer: comprehensive review. BJS Open. 2024;8:zrae038. https:\/\/doi.org\/10.1093\/bjsopen\/zrae038.","journal-title":"BJS Open"},{"key":"9320_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11864-024-01184-6","volume":"25","author":"KG Nair","year":"2024","unstructured":"Nair KG, Kamath SD, Chowattukunnel N, Krishnamurthi SS. Preoperative strategies for locally advanced colon cancer. Curr Treat Options Oncol. 2024;25:376\u201388. https:\/\/doi.org\/10.1007\/s11864-024-01184-6.","journal-title":"Curr Treat Options Oncol"},{"key":"9320_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12931-017-0545-6","volume":"18","author":"B Shang","year":"2017","unstructured":"Shang B, Jia Y, Chen G, Wang Z. Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin\/pemetrexed-induced apoptosis in A549 cells. Respir Res. 2017;18:56. https:\/\/doi.org\/10.1186\/s12931-017-0545-6.","journal-title":"Respir Res"},{"key":"9320_CR4","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.7150\/thno.46460","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Guo S, Kim SJ, Shao F, Ho JWK, Wong KU, et al. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel. Theranostics. 2021;11:2442\u201359. https:\/\/doi.org\/10.7150\/thno.46460.","journal-title":"Theranostics"},{"key":"9320_CR5","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1038\/s41388-023-02835-y","volume":"42","author":"PM Kasi","year":"2023","unstructured":"Kasi PM, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, et al. Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer. Oncogene. 2023;42:3252\u20139. https:\/\/doi.org\/10.1038\/s41388-023-02835-y.","journal-title":"Oncogene"},{"key":"9320_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/jpm14030266","volume":"14","author":"HD Li\u0219cu","year":"2024","unstructured":"Li\u0219cu HD, Antone-Iordache IL, Atasiei DI, Anghel IV, Ilie AT, Emamgholivand T, et al. The impact on survival of neoadjuvant treatment interruptions in locally advanced rectal cancer patients. J Pers Med. 2024;14:266. https:\/\/doi.org\/10.3390\/jpm14030266.","journal-title":"J Pers Med"},{"key":"9320_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2559.2011.03980.x","volume":"59","author":"SY Park","year":"2011","unstructured":"Park SY, Chang HJ, Kim DY, Jung KH, Kim SY, Park JW, et al. Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy? Histopathology. 2011;59:650\u20139. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03980.x.","journal-title":"Histopathology"},{"key":"9320_CR8","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.breast.2021.11.009","volume":"62","author":"G Viale","year":"2022","unstructured":"Viale G, Fusco N. Pathology after neoadjuvant treatment\u2014how to assess residual disease. Breast. 2022;62:S25\u20138. https:\/\/doi.org\/10.1016\/j.breast.2021.11.009.","journal-title":"Breast"},{"key":"9320_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33080-8","volume":"13","author":"WT Ju","year":"2022","unstructured":"Ju WT, Xia RH, Zhu DW, Dou SJ, Zhu GP, Dong MJ, et al. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nat Commun. 2022;13:5378. https:\/\/doi.org\/10.1038\/s41467-022-33080-8.","journal-title":"Nat Commun"},{"key":"9320_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","volume":"15","author":"WD Travis","year":"2020","unstructured":"Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, et al. IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy. J Thorac Oncol. 2020;15:709\u201340. https:\/\/doi.org\/10.1016\/j.jtho.2020.01.005.","journal-title":"J Thorac Oncol"},{"key":"9320_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1159\/000519746","volume":"14","author":"Y Usui","year":"2021","unstructured":"Usui Y, Matsunuma R, Yamaguchi K, Hayami R, Muramatsu A, Suzuki M, et al. Pathological complete response to neoadjuvant chemotherapy in a patient with HER2-positive squamous cell carcinoma of the breast. Case Rep Oncol. 2021;14:1536\u201341. https:\/\/doi.org\/10.1159\/000519746.","journal-title":"Case Rep Oncol"},{"key":"9320_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.814989","volume":"12","author":"F Inzani","year":"2022","unstructured":"Inzani F, Arciuolo D, Angelico G, Santoro A, Travaglino A, D\u2019Alessandris N, et al. Assessing post-treatment pathologic tumor response in female genital tract carcinomas: an update. Front Oncol. 2022;12:814989. https:\/\/doi.org\/10.3389\/fonc.2022.814989.","journal-title":"Front Oncol"},{"key":"9320_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jtho.2018.11.017","volume":"14","author":"Y Qu","year":"2019","unstructured":"Qu Y, Emoto K, Eguchi T, Aly RG, Zheng H, Chaft JE, et al. Pathologic assessment after neoadjuvant chemotherapy for NSCLC: importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma. J Thorac Oncol. 2019;14:482\u201393. https:\/\/doi.org\/10.1016\/j.jtho.2018.11.017.","journal-title":"J Thorac Oncol"},{"key":"9320_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41591-023-02758-x","volume":"30","author":"YL Verschoor","year":"2024","unstructured":"Verschoor YL, van de Haar J, van den Berg JG, van Sandick JW, Kodach LL, van Dieren JM, et al. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial. Nat Med. 2024;30:519\u201330. https:\/\/doi.org\/10.1038\/s41591-023-02758-x.","journal-title":"Nat Med"},{"key":"9320_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.3253","volume":"16","author":"S Arandjelovic","year":"2015","unstructured":"Arandjelovic S, Ravichandran KS. Phagocytosis of apoptotic cells in homeostasis. Nat Immunol. 2015;16:907\u201317. https:\/\/doi.org\/10.1038\/ni.3253.","journal-title":"Nat Immunol"},{"key":"9320_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","volume":"21","author":"E Boada-Romero","year":"2020","unstructured":"Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21:398\u2013414. https:\/\/doi.org\/10.1038\/s41580-020-0232-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9320_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran AC, Yurdagul A, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20:254\u201367. https:\/\/doi.org\/10.1038\/s41577-019-0240-6.","journal-title":"Nat Rev Immunol"},{"key":"9320_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.873226","volume":"10","author":"K Ahmadzadeh","year":"2022","unstructured":"Ahmadzadeh K, Vanoppen M, Rose CD, Matthys P, Wouters CH. Multinucleated giant cells: current insights in phenotype, biological activities, and mechanism of formation. Front Cell Dev Biol. 2022;10:873226. https:\/\/doi.org\/10.3389\/fcell.2022.873226.","journal-title":"Front Cell Dev Biol"},{"key":"9320_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51020-3","volume":"9","author":"MAC Fontaine","year":"2019","unstructured":"Fontaine MAC, Westra MM, Bot I, Jin H, Franssen A, Bot M, et al. Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells. Sci Rep. 2019;9:14547. https:\/\/doi.org\/10.1038\/s41598-019-51020-3.","journal-title":"Sci Rep"},{"key":"9320_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejphar.2017.10.005","volume":"816","author":"J Nagenborg","year":"2017","unstructured":"Nagenborg J, Goossens P, Biessen EAL, Donners MMPC. Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: implications for treatment. Eur J Pharmacol. 2017;816:14\u201324. https:\/\/doi.org\/10.1016\/j.ejphar.2017.10.005.","journal-title":"Eur J Pharmacol"},{"key":"9320_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.yexmp.2015.11.010","volume":"99","author":"JH Qiao","year":"2015","unstructured":"Qiao JH, Mishra V, Fishbein MC, Sinha SK, Rajavashisth TB. Multinucleated giant cells in atherosclerotic plaques of human carotid arteries: identification of osteoclast-like cells and their specific proteins in artery wall. Exp Mol Pathol. 2015;99:654\u201362. https:\/\/doi.org\/10.1016\/j.yexmp.2015.11.010.","journal-title":"Exp Mol Pathol"},{"key":"9320_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add9871","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Xing Z, Geng M, Zhao R, Yang X, Zhu X, et al. Macrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor response. Sci Adv. 2023;9:eadd9871. https:\/\/doi.org\/10.1126\/sciadv.add9871.","journal-title":"Sci Adv"},{"key":"9320_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe7915","volume":"6","author":"C Nakahashi-Oda","year":"2021","unstructured":"Nakahashi-Oda C, Fujiyama S, Nakazawa Y, Kanemaru K, Wang Y, Lyu W, et al. CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke. Sci Immunol. 2021;6:eabe7915. https:\/\/doi.org\/10.1126\/sciimmunol.abe7915.","journal-title":"Sci Immunol"},{"key":"9320_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41590-022-01403-y","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Tada M, Cai Z, Andhey PS, Swain A, Miller KR, et al. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia. Nat Immunol. 2023;24:545\u201357. https:\/\/doi.org\/10.1038\/s41590-022-01403-y.","journal-title":"Nat Immunol"},{"key":"9320_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71132-9","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang M, Duan Y, Gan H, Jiang N, Qin L, Luo Y, et al. TYROBP serve as potential immune-related signature genes in the acute phase of intracerebral hemorrhage. Sci Rep. 2024;14:20158. https:\/\/doi.org\/10.1038\/s41598-024-71132-9.","journal-title":"Sci Rep"},{"key":"9320_CR26","doi-asserted-by":"publisher","first-page":"ra11","DOI":"10.1126\/scisignal.1159665","volume":"1","author":"L Helming","year":"2008","unstructured":"Helming L, Tomasello E, Kyriakides TR, Martinez FO, Takai T, Gordon S, et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal. 2008;1:ra11. https:\/\/doi.org\/10.1126\/scisignal.1159665.","journal-title":"Sci Signal"},{"key":"9320_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1600-065X.2006.00466.x","volume":"214","author":"R Takaki","year":"2006","unstructured":"Takaki R, Watson SR, Lanier LL. DAP12: an adapter protein with dual functionality. Immunol Rev. 2006;214:118\u201329. https:\/\/doi.org\/10.1111\/j.1600-065X.2006.00466.x.","journal-title":"Immunol Rev"},{"key":"9320_CR28","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/eji.200425932","volume":"35","author":"E Tomasello","year":"2005","unstructured":"Tomasello E, Vivier E. KARAP\/DAP12\/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol. 2005;35:1670\u20137. https:\/\/doi.org\/10.1002\/eji.200425932.","journal-title":"Eur J Immunol"},{"key":"9320_CR29","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23:580\u201394. https:\/\/doi.org\/10.1038\/s41577-023-00837-1.","journal-title":"Nat Rev Immunol"},{"key":"9320_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-021-00312-y","volume":"7","author":"LH Che","year":"2021","unstructured":"Che LH, Liu JW, Huo JP, Luo R, Xu RM, He C, et al. A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy. Cell Discov. 2021;7:80. https:\/\/doi.org\/10.1038\/s41421-021-00312-y.","journal-title":"Cell Discov"},{"key":"9320_CR31","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ccell.2025.10.008","volume":"43","author":"Q Gao","year":"2025","unstructured":"Gao Q, Ling X, Liao L, Tang F, Jiang Y, Qin S, et al. Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer. Cancer Cell. 2025;43:2282\u201397.e9. https:\/\/doi.org\/10.1016\/j.ccell.2025.10.008.","journal-title":"Cancer Cell"},{"key":"9320_CR32","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"MF Oliveira","year":"2025","unstructured":"Oliveira MF, Romero JP, Chung M, Williams SR, Gottscho AD, Gupta A, et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet. 2025;57:1512\u201323. https:\/\/doi.org\/10.1038\/s41588-025-02193-3.","journal-title":"Nat Genet"},{"key":"9320_CR33","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888\u2013902.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"key":"9320_CR34","doi-asserted-by":"publisher","first-page":"e24777","DOI":"10.4161\/jkst.24777","volume":"2","author":"T Miyamoto","year":"2013","unstructured":"Miyamoto T. STATs and macrophage fusion. JAKSTAT. 2013;2:e24777. https:\/\/doi.org\/10.4161\/jkst.24777.","journal-title":"JAKSTAT"},{"key":"9320_CR35","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1007\/s00018-021-03875-x","volume":"78","author":"O Dufran\u00e7ais","year":"2021","unstructured":"Dufran\u00e7ais O, Mascarau R, Poincloux R, Maridonneau-Parini I, Raynaud-Messina B, V\u00e9rollet C. Cellular and molecular actors of myeloid cell fusion: podosomes and tunneling nanotubes call the tune. Cell Mol Life Sci. 2021;78:6087\u2013104. https:\/\/doi.org\/10.1007\/s00018-021-03875-x.","journal-title":"Cell Mol Life Sci"},{"key":"9320_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396. https:\/\/doi.org\/10.1126\/science.aad0501.","journal-title":"Science"},{"key":"9320_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1042\/bst20110636","volume":"40","author":"A O\u2019Donnell","year":"2012","unstructured":"O\u2019Donnell A, Odrowaz Z, Sharrocks AD. Immediate-early gene activation by the MAPK pathways: what do and don\u2019t we know? Biochem Soc Trans. 2012;40:58\u201366. https:\/\/doi.org\/10.1042\/bst20110636.","journal-title":"Biochem Soc Trans"},{"key":"9320_CR38","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","volume":"73","author":"D Lake","year":"2016","unstructured":"Lake D, Corr\u00eaa SA, M\u00fcller J. Negative feedback regulation of the ERK1\/2 MAPK pathway. Cell Mol Life Sci. 2016;73:4397\u2013413. https:\/\/doi.org\/10.1007\/s00018-016-2297-8.","journal-title":"Cell Mol Life Sci"},{"key":"9320_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-018-0051-4","volume":"2","author":"MC Wagle","year":"2018","unstructured":"Wagle MC, Kirouac D, Klijn C, Liu B, Mahajan S, Junttila M, et al. A transcriptional MAPK pathway activity score (MPAS) is a clinically relevant biomarker in multiple cancer types. NPJ Precis Oncol. 2018;2:7. https:\/\/doi.org\/10.1038\/s41698-018-0051-4.","journal-title":"NPJ Precis Oncol"},{"key":"9320_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279\u201384. https:\/\/doi.org\/10.1016\/s0166-4328(01)00297-2.","journal-title":"Behav Brain Res"},{"key":"9320_CR41","doi-asserted-by":"publisher","unstructured":"Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3:180\u20135. https:\/\/doi.org\/10.1002\/wics.147.","DOI":"10.1002\/wics.147"},{"key":"9320_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20050645","volume":"202","author":"M Yagi","year":"2005","unstructured":"Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005;202:345\u201351. https:\/\/doi.org\/10.1084\/jem.20050645.","journal-title":"J Exp Med"},{"key":"9320_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2021.2024941","volume":"11","author":"J Lin","year":"2022","unstructured":"Lin J, Xu A, Jin J, Zhang M, Lou J, Qian C, et al. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. Oncoimmunology. 2022;11:2024941. https:\/\/doi.org\/10.1080\/2162402x.2021.2024941.","journal-title":"Oncoimmunology"},{"key":"9320_CR44","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-21-4260","volume":"82","author":"YT Wei","year":"2022","unstructured":"Wei YT, Wang XR, Yan C, Huang F, Zhang Y, Liu X, et al. Thymosin \u03b1-1 reverses M2 polarization of tumor-associated macrophages during efferocytosis. Cancer Res. 2022;82:1991\u20132002. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4260.","journal-title":"Cancer Res"},{"key":"9320_CR45","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.4049\/jimmunol.0900006","volume":"182","author":"S Naidu","year":"2009","unstructured":"Naidu S, Vijayan V, Santoso S, Kietzmann T, Immenschuh S. Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2. J Immunol. 2009;182:7048\u201357. https:\/\/doi.org\/10.4049\/jimmunol.0900006.","journal-title":"J Immunol"},{"key":"9320_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/352371","volume":"2014","author":"Y Yang","year":"2014","unstructured":"Yang Y, Kim SC, Yu T, Yi YS, Rhee MH, Sung GH, et al. Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediators Inflamm. 2014;2014:352371. https:\/\/doi.org\/10.1155\/2014\/352371.","journal-title":"Mediators Inflamm"},{"key":"9320_CR47","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3892\/ijmm.2017.3143","volume":"40","author":"H Bian","year":"2017","unstructured":"Bian H, Li F, Wang W, Zhao Q, Gao S, Ma J, et al. MAPK\/p38 regulation of cytoskeleton rearrangement accelerates induction of macrophage activation by TLR4, but not TLR3. Int J Mol Med. 2017;40:1495\u2013503. https:\/\/doi.org\/10.3892\/ijmm.2017.3143.","journal-title":"Int J Mol Med"},{"key":"9320_CR48","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.3390\/ijms21165685","volume":"21","author":"J Kodama","year":"2020","unstructured":"Kodama J, Kaito T. Osteoclast multinucleation: review of current literature. Int J Mol Sci. 2020;21:5685. https:\/\/doi.org\/10.3390\/ijms21165685.","journal-title":"Int J Mol Sci"},{"key":"9320_CR49","doi-asserted-by":"publisher","first-page":"e24780","DOI":"10.1371\/journal.pone.0024780","volume":"6","author":"Y He","year":"2011","unstructured":"He Y, Staser K, Rhodes SD, Liu Y, Wu X, Park SJ, et al. Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS ONE. 2011;6:e24780. https:\/\/doi.org\/10.1371\/journal.pone.0024780.","journal-title":"PLoS ONE"},{"key":"9320_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-022-00552-w","volume":"17","author":"JV Haure-Mirande","year":"2022","unstructured":"Haure-Mirande JV, Audrain M, Ehrlich ME, Gandy S. Microglial TYROBP\/DAP12 in Alzheimer\u2019s disease: transduction of physiological and pathological signals across TREM2. Mol Neurodegener. 2022;17:55. https:\/\/doi.org\/10.1186\/s13024-022-00552-w.","journal-title":"Mol Neurodegener"},{"key":"9320_CR51","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","volume":"21","author":"P Mehrotra","year":"2022","unstructured":"Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022;21:601\u201320. https:\/\/doi.org\/10.1038\/s41573-022-00470-y.","journal-title":"Nat Rev Drug Discov"},{"key":"9320_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2021.101090","volume":"27","author":"R Nagesh","year":"2021","unstructured":"Nagesh R, Kiran Kumar KM, Naveen Kumar M, Patil RH, Sharma SC. Regulation of Jun and Fos AP-1 transcription factors by JNK MAPKs signaling cascade in areca nut extract treated KB cells. Biochem Biophys Rep. 2021;27:101090. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101090.","journal-title":"Biochem Biophys Rep"},{"key":"9320_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbamcr.2014.12.013","volume":"1853","author":"J Shan","year":"2015","unstructured":"Shan J, Donelan W, Hayner JN, Zhang F, Dudenhausen EE, Kilberg MS. MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells. Biochim Biophys Acta Mol Cell Res. 2015;1853:539\u201348. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.12.013.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"9320_CR54","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","volume":"3","author":"Q Peng","year":"2010","unstructured":"Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3:ra38. https:\/\/doi.org\/10.1126\/scisignal.2000500.","journal-title":"Sci Signal"},{"key":"9320_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fncel.2019.00457","volume":"13","author":"H Yao","year":"2019","unstructured":"Yao H, Coppola K, Schweig JE, Crawford F, Mullan M, Paris D. Distinct signaling pathways regulate TREM2 phagocytic and NF\u03baB antagonistic activities. Front Cell Neurosci. 2019;13:457. https:\/\/doi.org\/10.3389\/fncel.2019.00457.","journal-title":"Front Cell Neurosci"},{"key":"9320_CR56","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1158\/2159-8290.Cd-24-0018","volume":"14","author":"G Gessain","year":"2024","unstructured":"Gessain G, Anzali AA, Lerousseau M, Mulder K, Bied M, Auperin A, et al. TREM2-expressing multinucleated giant macrophages are a biomarker of good prognosis in head and neck squamous cell carcinoma. Cancer Discov. 2024;14:2352\u201366. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0018.","journal-title":"Cancer Discov"},{"key":"9320_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jbm.a.35579","volume":"104","author":"M Barbeck","year":"2016","unstructured":"Barbeck M, Motta A, Migliaresi C, Sader R, Kirkpatrick CJ, Ghanaati S. Heterogeneity of biomaterial-induced multinucleated giant cells: possible importance for the regeneration process? J Biomed Mater Res A. 2016;104:413\u20138. https:\/\/doi.org\/10.1002\/jbm.a.35579.","journal-title":"J Biomed Mater Res A"},{"key":"9320_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/ten.teb.2017.0242","volume":"24","author":"RJ Miron","year":"2017","unstructured":"Miron RJ, Bosshardt DD. Multinucleated giant cells: good guys or bad guys? Tissue Eng Part B Rev. 2017;24:53\u201365. https:\/\/doi.org\/10.1089\/ten.teb.2017.0242.","journal-title":"Tissue Eng Part B Rev"},{"key":"9320_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.actbio.2016.07.003","volume":"43","author":"R Klopfleisch","year":"2016","unstructured":"Klopfleisch R. Macrophage reaction against biomaterials in the mouse model\u2014phenotypes, functions and markers. Acta Biomater. 2016;43:3\u201313. https:\/\/doi.org\/10.1016\/j.actbio.2016.07.003.","journal-title":"Acta Biomater"},{"key":"9320_CR60","doi-asserted-by":"publisher","unstructured":"Yang HC, Park HC, Quan H, Kim Y. Immunomodulation of biomaterials by controlling macrophage polarization. In: Noh I, editor. Biomimetic medical materials: from nanotechnology to 3D bioprinting. Singapore: Springer Singapore; 2018. pp. 197\u2013206. https:\/\/doi.org\/10.1007\/978-981-13-0445-3_12.","DOI":"10.1007\/978-981-13-0445-3_12"},{"key":"9320_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo7027","volume":"384","author":"I Liebold","year":"2024","unstructured":"Liebold I, Al Jawazneh A, Casar C, Lanzloth C, Leyk S, Hamley M, et al. Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages. Science. 2024;384:eabo7027. https:\/\/doi.org\/10.1126\/science.abo7027.","journal-title":"Science"},{"key":"9320_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46735-5","volume":"15","author":"M Cheng","year":"2024","unstructured":"Cheng M, Chen S, Li K, Wang G, Xiong G, Ling R, et al. CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer. Nat Commun. 2024;15:2818. https:\/\/doi.org\/10.1038\/s41467-024-46735-5.","journal-title":"Nat Commun"},{"key":"9320_CR63","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371. https:\/\/doi.org\/10.1016\/j.cell.2015.01.049.","journal-title":"Cell"},{"key":"9320_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01642-6","volume":"22","author":"Y Yan","year":"2024","unstructured":"Yan Y, Bai S, Han H, Dai J, Niu L, Wang H, et al. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2\/STAT3 and NF-\u03baB pathways. Cell Commun Signal. 2024;22:272. https:\/\/doi.org\/10.1186\/s12964-024-01642-6.","journal-title":"Cell Commun Signal"},{"key":"9320_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109844","volume":"37","author":"M Binnewies","year":"2021","unstructured":"Binnewies M, Pollack JL, Rudolph J, Dash S, Abushawish M, Lee T, et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep. 2021;37:109844. https:\/\/doi.org\/10.1016\/j.celrep.2021.109844.","journal-title":"Cell Rep"},{"key":"9320_CR66","doi-asserted-by":"publisher","first-page":"LB071","DOI":"10.1158\/1538-7445.AM2021-LB071","volume":"81","author":"NS Jahchan","year":"2021","unstructured":"Jahchan NS, Binnewies M, Pollack JL, Mehta R, Dash S, Tun C, et al. Abstract LB071: Tuning the tumor myeloid microenvironment (TME) by targeting TREM2+ tumor-associated macrophages to overcome resistance to immune checkpoint inhibitors. Cancer Res. 2021;81:LB071. https:\/\/doi.org\/10.1158\/1538-7445.AM2021-LB071.","journal-title":"Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09320-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09320-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09320-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:01:45Z","timestamp":1792918905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09320-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9320"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09320-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The animal study was reviewed and approved by the Experimental Animal Ethics Committee of Anhui Medical University (ethics number: LLSC20231324). This study was conducted in accordance with the principles of the Declaration of Helsinki. The use of clinical pathological specimens in this study was reviewed and approved by the Biomedical Ethics Committee of Anhui Medical University (No. 83230484).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"907"}}